发明授权
- 专利标题： Pyrimidineamide derivatives and the use thereof
- 专利标题（中）： 嘧啶酰胺衍生物及其用途
-
申请号： US10528913申请日： 2003-09-26
-
公开(公告)号： US07655669B2公开(公告)日： 2010-02-02
- 发明人: Paul William Manley , Werner Breitenstein , Sandra Jacob , Pascal Furet
- 申请人： Paul William Manley , Werner Breitenstein , Sandra Jacob , Pascal Furet
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 优先权： GB0222514.2 20020927
- 国际申请： PCT/EP03/10724 WO 20030926
- 国际公布： WO2004/029038 WO 20040408
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; A61K31/506
摘要：
The invention relates to novel substituted N-(3-benzoylaminophenyl)-4-pyridyl-2-pyrimidinamine derivatives, processes for the preparation thereof, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease, and a method for the treatment of such a disease.
公开/授权文献
- US20060142577A1 Novel pyrimidineamide derivatives and the use thereof 公开/授权日：2006-06-29
信息查询
